Literature DB >> 19294766

Ex-vivo evaluation of gene therapy vectors in human pancreatic (cancer) tissue slices.

Michael-A van Geer1, Koert F D Kuhlmann, Conny T Bakker, Fibo J W ten Kate, Ronald P J Oude Elferink, Piter J Bosma.   

Abstract

AIM: To culture human pancreatic tissue obtained from small resection specimens as a pre-clinical model for examining virus-host interactions.
METHODS: Human pancreatic tissue samples (malignant and normal) were obtained from surgical specimens and processed immediately to tissue slices. Tissue slices were cultured ex vivo for 1-6 d in an incubator using 95% O(2). Slices were subsequently analyzed for viability and morphology. In addition the slices were incubated with different viral vectors expressing the reporter genes GFP or DsRed. Expression of these reporter genes was measured at 72 h after infection.
RESULTS: With the Krumdieck tissue slicer, uniform slices could be generated from pancreatic tissue but only upon embedding the tissue in 3% low melting agarose. Immunohistological examination showed the presence of all pancreatic cell types. Pancreatic normal and cancer tissue slices could be cultured for up to 6 d, while retaining viability and a moderate to good morphology. Reporter gene expression indicated that the slices could be infected and transduced efficiently by adenoviral vectors and by adeno associated viral vectors, whereas transduction with lentiviral vectors was limited. For the adenoviral vector, the transduction seemed limited to the peripheral layers of the explants.
CONCLUSION: The presented system allows reproducible processing of minimal amounts of pancreatic tissue into slices uniform in size, suitable for pre-clinical evaluation of gene therapy vectors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19294766      PMCID: PMC2658838          DOI: 10.3748/wjg.15.1359

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

Review 1.  Precision-cut organ slices as a tool to study toxicity and metabolism of xenobiotics with special reference to non-hepatic tissues.

Authors:  R de Kanter; M Monshouwer; D K F Meijer; G M M Groothuis
Journal:  Curr Drug Metab       Date:  2002-02       Impact factor: 3.731

2.  A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob.

Authors:  H Mizuguchi; N Koizumi; T Hosono; N Utoguchi; Y Watanabe; M A Kay; T Hayakawa
Journal:  Gene Ther       Date:  2001-05       Impact factor: 5.250

3.  Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.

Authors:  J G Wesseling; P J Bosma; V Krasnykh; E A Kashentseva; J L Blackwell; P N Reynolds; H Li; M Parameshwar; S M Vickers; E M Jaffee; K Huibregtse; D T Curiel; I Dmitriev
Journal:  Gene Ther       Date:  2001-07       Impact factor: 5.250

4.  The organotypic multicellular spheroid is a relevant three-dimensional model to study adenovirus replication and penetration in human tumors in vitro.

Authors:  Jacques Grill; Martine L M Lamfers; Victor W van Beusechem; Clemens M Dirven; D Shareen Pherai; Mathijs Kater; Paul Van der Valk; Ronald Vogels; W Peter Vandertop; Herbert M Pinedo; David T Curiel; Winald R Gerritsen
Journal:  Mol Ther       Date:  2002-11       Impact factor: 11.454

5.  Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial.

Authors:  S Mulvihill; R Warren; A Venook; A Adler; B Randlev; C Heise; D Kirn
Journal:  Gene Ther       Date:  2001-02       Impact factor: 5.250

Review 6.  Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

Authors:  D Kirn
Journal:  Gene Ther       Date:  2001-01       Impact factor: 5.250

7.  An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy.

Authors:  C Heise; T Hermiston; L Johnson; G Brooks; A Sampson-Johannes; A Williams; L Hawkins; D Kirn
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

8.  Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes.

Authors:  Jurgen Seppen; Martijn Rijnberg; Michel P Cooreman; Ronald P J Oude Elferink
Journal:  J Hepatol       Date:  2002-04       Impact factor: 25.083

9.  Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats.

Authors:  Jurgen Seppen; Conny Bakker; Berry de Jong; Cindy Kunne; Karin van den Oever; Kristin Vandenberghe; Rudi de Waart; Jaap Twisk; Piter Bosma
Journal:  Mol Ther       Date:  2006-04-03       Impact factor: 11.454

10.  Nonadhesive organ culture of human exocrine pancreatic cells with their stroma.

Authors:  Dag Hoem; Helge Dalen; Ake Andrén-Sandberg; Jens Höstmark
Journal:  Pancreas       Date:  2002-07       Impact factor: 3.327

View more
  16 in total

1.  Sensitization of pancreatic cancer to chemoradiation by the Chk1 inhibitor MK8776.

Authors:  Carl G Engelke; Leslie A Parsels; Yushen Qian; Qiang Zhang; David Karnak; Jordan R Robertson; Daria M Tanska; Dongping Wei; Mary A Davis; Joshua D Parsels; Lili Zhao; Joel K Greenson; Theodore S Lawrence; Jonathan Maybaum; Meredith A Morgan
Journal:  Clin Cancer Res       Date:  2013-06-26       Impact factor: 12.531

2.  Relevance of humanized three-dimensional tumor tissue models: a descriptive systematic literature review.

Authors:  D Contartese; Francesca Salamanna; F Veronesi; M Fini
Journal:  Cell Mol Life Sci       Date:  2020-04-13       Impact factor: 9.261

3.  Modeling pancreatic cancer with organoids.

Authors:  Lindsey A Baker; Hervé Tiriac; Hans Clevers; David A Tuveson
Journal:  Trends Cancer       Date:  2016-04

4.  Frontiers in Suicide Gene Therapy of Cancer.

Authors:  Marek Malecki
Journal:  J Genet Syndr Gene Ther       Date:  2012-10-22

5.  Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma.

Authors:  David Roife; Bingbing Dai; Ya'an Kang; Mayrim V Rios Perez; Michael Pratt; Xinqun Li; Jason B Fleming
Journal:  Clin Cancer Res       Date:  2016-06-03       Impact factor: 12.531

6.  Organotypic culture of breast tumor explants as a multicellular system for the screening of natural compounds with antineoplastic potential.

Authors:  Irma Edith Carranza-Torres; Nancy Elena Guzmán-Delgado; Consuelo Coronado-Martínez; José Inocente Bañuelos-García; Ezequiel Viveros-Valdez; Javier Morán-Martínez; Pilar Carranza-Rosales
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

Review 7.  Human Organ Culture: Updating the Approach to Bridge the Gap from In Vitro to In Vivo in Inflammation, Cancer, and Stem Cell Biology.

Authors:  Rafia S Al-Lamki; John R Bradley; Jordan S Pober
Journal:  Front Med (Lausanne)       Date:  2017-09-11

8.  An in vitro model of human acute ethanol exposure that incorporates CXCR3- and CXCR4-dependent recruitment of immune cells.

Authors:  Sumera Karim; Evaggelia Liaskou; Samuel Hadley; Janine Youster; Jeff Faint; David H Adams; Patricia F Lalor
Journal:  Toxicol Sci       Date:  2013-01-08       Impact factor: 4.849

Review 9.  Does the Microenvironment Hold the Hidden Key for Functional Precision Medicine in Pancreatic Cancer?

Authors:  John Kokkinos; Anya Jensen; George Sharbeen; Joshua A McCarroll; David Goldstein; Koroush S Haghighi; Phoebe A Phillips
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

10.  Hypoxia pathways and cellular stress activate pancreatic stellate cells: development of an organotypic culture model of thick slices of normal human pancreas.

Authors:  Vinciane Rebours; Miguel Albuquerque; Alain Sauvanet; Philippe Ruszniewski; Philippe Lévy; Valérie Paradis; Pierre Bedossa; Anne Couvelard
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.